Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Gerratana

Showing results (51-60 of 127) with videos related to

Pageof 13
Sort By:
Molecular Oncology|May 27, 2026
ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept studyDimitra Stergiopoulou, Athina Markou, Eleonora Nicolo, et al.
Oncotarget|February 7, 2022
Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancersAmi N Shah, Ashwin Sunderraj, Brian Finkelman, et al.
Future Oncology (London, England)|March 13, 2018
Comparison of primary breast cancer and paired metastases: biomarkers discordance influence on outcome and therapyElena Ongaro, Lorenzo Gerratana, Marika Cinausero, et al.
Critical Reviews in Oncology/Hematology|December 30, 2019
Performance of a novel Next Generation Sequencing circulating tumor DNA (ctDNA) platform for the evaluation of samples from patients with metastatic breast cancer (MBC)Lorenzo Gerratana, Qiang Zhang, Ami Naimish Shah, et al.
Scientific Reports|June 10, 2026
AI-assisted extraction of opportunistic findings from oncologic CT reports using large language modelsKevin Roitero, Luigi Nardone, Davide Lacitignola, et al.
Ebiomedicine|July 25, 2020
Landscape of circulating tumour DNA in metastatic breast cancerAndrew A Davis, Saya Jacob, Lorenzo Gerratana, et al.
Cancer|July 9, 2026
Circulating tumor DNA in early breast cancer: Evidence, challenges, next stepsSerena Di Cosimo, Valentina Appierto, Carolina Reduzzi, et al.
Breast Cancer Research : BCR|March 11, 2016
In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosisMichela Bulfoni, Lorenzo Gerratana, Fabio Del Ben, et al.
Future Oncology (London, England)|June 30, 2020
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world studyMarta Bonotto, Debora Basile, Lorenzo Gerratana, et al.
Frontiers in Pharmacology|August 9, 2022
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast CancerRossana Roncato, Lorenzo Gerratana, Lorenza Palmero, et al.
Pageof 13

Showing results (51-60 of 127) with videos related to

Sort By:
Pageof 13
Molecular Oncology|May 27, 2026
ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept studyDimitra Stergiopoulou, Athina Markou, Eleonora Nicolo, et al.
Oncotarget|February 7, 2022
Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancersAmi N Shah, Ashwin Sunderraj, Brian Finkelman, et al.
Future Oncology (London, England)|March 13, 2018
Comparison of primary breast cancer and paired metastases: biomarkers discordance influence on outcome and therapyElena Ongaro, Lorenzo Gerratana, Marika Cinausero, et al.
Critical Reviews in Oncology/Hematology|December 30, 2019
Performance of a novel Next Generation Sequencing circulating tumor DNA (ctDNA) platform for the evaluation of samples from patients with metastatic breast cancer (MBC)Lorenzo Gerratana, Qiang Zhang, Ami Naimish Shah, et al.
Scientific Reports|June 10, 2026
AI-assisted extraction of opportunistic findings from oncologic CT reports using large language modelsKevin Roitero, Luigi Nardone, Davide Lacitignola, et al.
Ebiomedicine|July 25, 2020
Landscape of circulating tumour DNA in metastatic breast cancerAndrew A Davis, Saya Jacob, Lorenzo Gerratana, et al.
Cancer|July 9, 2026
Circulating tumor DNA in early breast cancer: Evidence, challenges, next stepsSerena Di Cosimo, Valentina Appierto, Carolina Reduzzi, et al.
Breast Cancer Research : BCR|March 11, 2016
In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosisMichela Bulfoni, Lorenzo Gerratana, Fabio Del Ben, et al.
Future Oncology (London, England)|June 30, 2020
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world studyMarta Bonotto, Debora Basile, Lorenzo Gerratana, et al.
Frontiers in Pharmacology|August 9, 2022
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast CancerRossana Roncato, Lorenzo Gerratana, Lorenza Palmero, et al.
Pageof 13